BioSpace News Archive

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD Micro Main Event on Wednesday, December 11 at 9:45 AM PST/ 12:45 PM ET at the Luxe Sunset Boulevard Hotel in Los Angeles

The Lawrence J. Ellison Institute for Transformative Medicine of USC is pleased to announce the appointment of Anna Barker, Ph.D., as its chief strategy officer, effective immediately.

Nephron Pharmaceuticals Corporation today announced a new partnership with National Medical Products Inc. – developer of the J-Tip Needle Free Injector – that provides patients with an easy-to-use and virtually pain-free delivery of anesthetic medications prior to medical procedures.

EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the efficacy and safety data from the REVERSE-SD clinical study were presented at the Clinical Trials in Alzheimer’s Disease (CTAD) meeting in San Diego by the principal investigator of the study, Professor Philip Scheltens of the VU Medical Center in Amsterdam, Netherlands.

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that Mr. Jed Latkin, Chief Executive Officer, will present at the 12th Annual LD Micro Main Event investor conference.

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today the appointment of Oleg Nodelman to its Board of Directors.

CooperCompanies announced financial results for the fiscal fourth quarter and full year ended October 31, 2019.

BIOASIS TECHNOLOGIES INC. is pleased to announce that all resolutions were passed by the requisite majority at its annual general meeting held earlier today in Toronto, Ontario.

Autolus Therapeutics plc announced that management will host a conference call and webcast on Monday, December 9, 2019 at 8:30 am ET / 1:30 pm GMT to review clinical data presented at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition.

Johnson & Johnson announced that Hubert Joly, Executive Chairman of Best Buy Co., Inc, and Mark A. Weinberger, Former EY Global Chairman and CEO, have been appointed to its Board of Directors..